Family-Focused CBT Skills App and Standard Self Help Options for Childhood Anxiety

Sponsor
Kansas City Center for Anxiety Treatment, P.A. (Industry)
Overall Status
Completed
CT.gov ID
NCT03269370
Collaborator
Virtually Better, Inc. (Industry)
110
1
4
16.5
6.7

Study Details

Study Description

Brief Summary

Anxiety disorders are among the most common psychological disorders, with prevalent onset in childhood and adolescence. While cognitive behavioral therapy (CBT) is considered the first-line treatment for pediatric anxiety, significant barriers remain in accessing CBT and other evidence-based treatments (EBTs), and credible self-help resources based in EBT concepts. This study evaluates a family-guided CBT game application (Anchors App), targeted to children ages 6-11 and their families, which focuses on delivering adaptive CBT-based coping skills to those who have sub-clinical to mild anxiety and related symptoms in a convenient and portable platform. Anchors App will be evaluated in two forms (standard and "parent-enhanced") in comparison to use of a self-help book or waitlist control. The rapid advancements in technology allows richer interactive capacity, content scalability, customizability, and subscription to a broader range of content, which this app capitalizes on in order to increase access to CBT skill concepts directly to pediatric stakeholder populations. If found to be effective, Anchors App has the opportunity to promote engagement of EBT concepts in every-day use through smartphone technology, and will change the landscape of mental health prevention and early intervention for children and families.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Anchors Away
  • Behavioral: Parent Enhanced Anchors Away
  • Behavioral: Self-Help E-Book
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
110 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
RCT with 4 arms, one being a waitlist arm that allows for re-randomization into one of the 3 "active" study arms.RCT with 4 arms, one being a waitlist arm that allows for re-randomization into one of the 3 "active" study arms.
Masking:
None (Open Label)
Masking Description:
There is no masking in this study.
Primary Purpose:
Prevention
Official Title:
Randomized Controlled Trial of a Family-focused CBT Skills App and Standard Self Help Options for Childhood Anxiety and Related Conditions
Actual Study Start Date :
Aug 17, 2018
Actual Primary Completion Date :
Dec 31, 2019
Actual Study Completion Date :
Dec 31, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: 1: Anchors Away

Family will receive access to the basic Anchors Away mobile app to test over 6 weeks.

Behavioral: Anchors Away
Modular Cognitive Behavioral Therapy delivered through a mobile app.

Experimental: 2: Parent Enhanced Anchors Away

Family will receive access to the Parent Enhanced Anchors Away mobile app to test over 6 weeks.

Behavioral: Parent Enhanced Anchors Away
Modular Cognitive Behavioral Therapy delivered through a mobile app. Extra modules will focus specifically on parenting skills relevant to having an anxious child.

Active Comparator: 3: Self-Help E-Book

Group 3 will receive the Self Help e-Book as a comparative condition (families provided a kindle version copy of "Helping Your Anxious Child: A Step-by-Step Guide" ; Rapee, Wignall, Spence, Lyneham, & Cobham, 2008).

Behavioral: Self-Help E-Book
Parents will read "Helping Your Anxious Child: A Step-by-Step Guide" (Rapee, Wignall, Spence, Lyneham, & Cobham, 2008)

No Intervention: 4: Waitlist Control

Group 4 will not receive any intervention, but will be randomized into an active study arm at 6 weeks.

Outcome Measures

Primary Outcome Measures

  1. Spence Children's Anxiety Scale - Parent/Child Report (SCAS) [Entry into study, 6 weeks, 12 weeks]

    Parent and child report of anxiety with 6 DSM-IV criteria sub scales. Measuring change in reported anxiety levels in these 6 different domains over time.

Secondary Outcome Measures

  1. DASS-21 [Entry into study, 6 weeks, 12 weeks]

    A screener for overall psychological distress of parent with sub scales assessing anxiety, depression, and stress.

  2. Centre for Epidemiological Studies- Depression Scale for Children (CES-DC) [Entry into study, 6 weeks, 12 weeks]

    A 20-item screener for childhood depression and psychological distress

  3. Anxiety Sensitivity Index- 3 (ASI-3) [Entry into study, 6 weeks, 12 weeks]

    A measure of parent anxiety sensitivity (fear of arousal-related sensations) in physical, social, and cognitive domains

  4. Child Anxiety Sensitivity Index (CASI) [Entry into study, 6 weeks, 12 weeks]

    A measure of sensitivity to symptoms of anxiety, similar to the ASI, measuring physical, social, and mental incapacitation concerns in children.

  5. Behavioral Inhibition Instrument (BII) [Entry into study, 6 weeks, 12 weeks]

    A parent-report measure of child behavioral inhibition, which has been determined to be a risk factor for later psychopathology, particularly anxiety.

  6. Treatment Status and Parent Confidence [Entry into study, 3 weeks, 6 weeks, 12 weeks]

    Self-report measure to ensure the child is not receiving outside interventions (as would disqualify them from study) and to gauge parents' confidence in managing child's symptoms

  7. Opinion on Intervention [6 weeks]

    Self-report measure to gauge families' thoughts on user-friendliness, perceived effectiveness of intervention, and likelihood to use again or recommend to others

Eligibility Criteria

Criteria

Ages Eligible for Study:
6 Years to 11 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Availability of mobile technology (e.g., smart phone, tablet)

  • Internet access

  • English language spoken in the home

Exclusion Criteria:
  • Child in current or recent (last 2 months) psychotherapy

  • Child currently taking psychotropic medication

  • Parent or child endorsing symptom greater than 2 standard deviations above the mean on clinical measures

  • Parents express feeling unable to assist child with current degree of symptoms

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kansas City Center for Anxiety Treatment, P.A. Overland Park Kansas United States 66212

Sponsors and Collaborators

  • Kansas City Center for Anxiety Treatment, P.A.
  • Virtually Better, Inc.

Investigators

  • Principal Investigator: Kathryn D Kriegshauser, PhD, Kansas City Center for Anxiety Treatment, P.A.
  • Principal Investigator: Lisa R Hale, PhD, Kansas City Center for Anxiety Treatment, P.A.
  • Principal Investigator: Margo Adams Larsen, PhD, Virtually Better, Inc.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Kansas City Center for Anxiety Treatment, P.A.
ClinicalTrials.gov Identifier:
NCT03269370
Other Study ID Numbers:
  • 2R44MH098470-03
First Posted:
Aug 31, 2017
Last Update Posted:
Sep 2, 2020
Last Verified:
Aug 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Kansas City Center for Anxiety Treatment, P.A.
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 2, 2020